# 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

> **NCT07333651** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Li Min** · enrollment: 90 (estimated)

## Conditions studied

- Oligometastatic Disease

## Interventions

- **OTHER:** Standard-of-Care Systemic Therapy
- **PROCEDURE:** 125I Seed Implantation

## Key facts

- **NCT ID:** NCT07333651
- **Lead sponsor:** Li Min
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333651, "125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07333651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*